Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00336908Phase 3Completed
A Phase 3 trial of Lipidem in inflammation, sepsis, sponsored by University of Alberta. Started Nov 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00336908.